Literature DB >> 21789078

Medical evaluation and management of urolithiasis.

Michelle Jo Semins1, Brian R Matlaga.   

Abstract

Nephrolithiasis is a highly prevalent condition with a high recurrence rate that has a large impact on the quality of life of those affected. It also poses a great financial burden on society. There have been great advancements in the surgical treatment of stone disease over the past several decades. The evolution of surgical technique appears to have overshadowed the importance of prevention of stone disease despite evidence showing medical therapies significantly decreasing stone recurrence rates. Herein we review the metabolic evaluation of stone formers with the use of specific blood and urine tests. We complete our discussion with a review of the medical management of stone formers providing both general recommendations as well as reviewing focused therapies for specific metabolic abnormalities and medical conditions.

Entities:  

Keywords:  calculi; kidney; metabolic evaluation; nephrolithiasis; prevention

Year:  2010        PMID: 21789078      PMCID: PMC3126068          DOI: 10.1177/1756287210369121

Source DB:  PubMed          Journal:  Ther Adv Urol        ISSN: 1756-2872


  25 in total

Review 1.  Renal stone disease: Causes, evaluation and medical treatment.

Authors:  Ita Pfeferman Heilberg; Nestor Schor
Journal:  Arq Bras Endocrinol Metabol       Date:  2006-08

2.  Urologic diseases in America project: urolithiasis.

Authors:  Margaret S Pearle; Elizabeth A Calhoun; Gary C Curhan
Journal:  J Urol       Date:  2005-03       Impact factor: 7.450

3.  Time trends in reported prevalence of kidney stones in the United States: 1976-1994.

Authors:  Kiriaki K Stamatelou; Mildred E Francis; Camille A Jones; Leroy M Nyberg; Gary C Curhan
Journal:  Kidney Int       Date:  2003-05       Impact factor: 10.612

Review 4.  Is there a need for medical evaluation and treatment of nephrolithiasis in the "age of lithotripsy"?

Authors:  G M Preminger
Journal:  Semin Urol       Date:  1994-02

5.  Comparison of two diets for the prevention of recurrent stones in idiopathic hypercalciuria.

Authors:  Loris Borghi; Tania Schianchi; Tiziana Meschi; Angela Guerra; Franca Allegri; Umberto Maggiore; Almerico Novarini
Journal:  N Engl J Med       Date:  2002-01-10       Impact factor: 91.245

6.  Ambulatory evaluation of nephrolithiasis. Classification, clinical presentation and diagnostic criteria.

Authors:  C Y Pak; F Britton; R Peterson; D Ward; C Northcutt; N A Breslau; J McGuire; K Sakhaee; S Bush; M Nicar; D A Norman; P Peters
Journal:  Am J Med       Date:  1980-07       Impact factor: 4.965

7.  Ambulatory evaluation of nephrolithiasis: an update of a 1980 protocol.

Authors:  F L Levy; B Adams-Huet; C Y Pak
Journal:  Am J Med       Date:  1995-01       Impact factor: 4.965

8.  Effect of dietary changes on urinary oxalate excretion and calcium oxalate supersaturation in patients with hyperoxaluric stone formation.

Authors:  Kristina L Penniston; Stephen Y Nakada
Journal:  Urology       Date:  2009-01-01       Impact factor: 2.649

Review 9.  Medical therapy of stone disease: from prevention to promotion of passage options.

Authors:  Michael Lipkin; Ojas Shah
Journal:  Curr Urol Rep       Date:  2009-01       Impact factor: 3.092

10.  Differentiating primary from secondary hyperparathyroidism in stone patients: the "thiazide challenge".

Authors:  Brian H Eisner; Jennifer Ahn; Marshall L Stoller
Journal:  J Endourol       Date:  2009-02       Impact factor: 2.942

View more
  6 in total

1.  Ureteric stenting vs not stenting following uncomplicated ureteroscopic lithotripsy: A prospective randomised trial.

Authors:  Saddam Al Demour; Adel Alrabadi; Abedallatif AlSharif; Mera Ababneh; Raed Al-Taher; Motaz Melhem; Hammam Mansi; Sa'id Aljamal; Mohammad Abufaraj
Journal:  Arab J Urol       Date:  2020-05-19

2.  Hydrochlorothiazide compared to chlorthalidone in reduction of urinary calcium in patients with kidney stones.

Authors:  Dawn F Wolfgram; Vinod Gundu; Brad C Astor; R Allan Jhagroo
Journal:  Urolithiasis       Date:  2013-05-10       Impact factor: 3.436

3.  Protective effect of ethyl acetate fraction of Biophytum sensitivum extract against sodium oxalate-induced urolithiasis in rats.

Authors:  Anil T Pawar; Niraj S Vyawahare
Journal:  J Tradit Complement Med       Date:  2017-01-17

4.  Predictive Factors for Achieving the Recommended AUA Daily Urine Production in Patients With Nephrolithiasis.

Authors:  Kimberly Tay; Anojan Navaratnam; Sean McAdams; Mira Keddis; Matthew Neville; Mitchell R Humphreys
Journal:  Mayo Clin Proc Innov Qual Outcomes       Date:  2019-05-27

5.  Antioxidant and Polyphenol-Rich Ethanolic Extract of Rubia tinctorum L. Prevents Urolithiasis in an Ethylene Glycol Experimental Model in Rats.

Authors:  Fatima Zahra Marhoume; Rachida Aboufatima; Younes Zaid; Youness Limami; Raphaël E Duval; Jawad Laadraoui; Anass Belbachir; Abderrahmane Chait; Abdallah Bagri
Journal:  Molecules       Date:  2021-02-14       Impact factor: 4.411

Review 6.  Detector-based spectral CT with a novel dual-layer technology: principles and applications.

Authors:  Negin Rassouli; Maryam Etesami; Amar Dhanantwari; Prabhakar Rajiah
Journal:  Insights Imaging       Date:  2017-10-06
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.